Patent · US Expired

Non-immunosuppressive immunogenic or vaccine composition comprising a mutated E7 protein of the HPV-16 virus

US7314629B2 · kind B2 · utility

8Cited by

1References

24Claims

0Family size

Assignee

NEOVACS · FR

Inventors

Daniel Zagury · Paris, FR
Helene Le Buanec · Paris, FR
Bernard Bizzini · Maurepas, FR

Key dates

Filing date	Apr 4, 2003
Grant date	Jan 1, 2008
Priority date	—
Expiry date	May 9, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/16322
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to an immunogenic or vaccine composition inducing an immune response towards the HPV-16 Papillomavirus native E7 protein, without simultaneously inducing an immunosuppression, said composition comprising, as the active ingredient, a non immunosuppressive mutated E7 protein, comprising the amino acid sequence consisting, from the N-terminal end to the C-terminal end, in:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.